ARTICLE | Company News
Diversa, Merck deal
June 27, 2005 7:00 AM UTC
The companies expanded a January deal to develop antibodies against an undisclosed MRK target using DVSA's MedEv antibody optimization technology (see BioCentury, Jan. 17). The companies did not discl...